ArcScan, Inc announced that it has entered into stock purchase agreement with new investor Shanghai Haohai Biological Technology Co., Ltd for private placement of preferred shares for gross proceeds of $11.15 million on July 21, 2021.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.95 HKD | +1.99% | +9.49% | +1.61% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.61% | 1.91B | |
-2.31% | 185B | |
-3.20% | 105B | |
-5.04% | 66.59B | |
+0.20% | 54.66B | |
+17.29% | 47.78B | |
+4.06% | 41.26B | |
+2.36% | 26.95B | |
+2.07% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- ArcScan, Inc. announced that it expects to receive $11.15 million in funding from Shanghai Haohai Biological Technology Co., Ltd.